- The jury ruled in which the metal-on-metal implants were defective
- Lawyer: Plaintiffs suffered “serious medical complications”
- Both companies denied wrongdoing as well as will appeal
A lawyer for the six plaintiffs said they suffered “serious medical complications caused by defective” metal-on-metal Pinnacle implants. The jurors found in which the companies failed to warn patients as well as their doctors about risks related to the defectively designed product.
Each of the patients had to undergo a second, or revision, surgery to replace the devices as well as repair tissue damage as well as bone erosion. At least one had received double hip implants.
The jury awarded more than $30 million in actual damages as well as more than $1 billion in punitive damages. Jurors ruled in which Johnson & Johnson as well as DePuy were negligent in designing the implant; failed to warn physicians as well as patients about concerns over the product; failed to recall the idea; as well as intentionally misrepresented the product’s effectiveness to patients as well as their doctors.
“Just as before, a jury has listened to the testimony of both sides, as well as returned a verdict affirming what we’ve known all along: a responsible company might settle these cases as well as take care of their injured consumers, rather than forcing them through expensive as well as vexatious litigation just to delay justice,” said lead attorney Mark Lanier of the Lanier Law Firm in Houston. “This specific jury spoke loud as well as clear, as well as I expect J&J will finally listen.”
Both Johnson & Johnson as well as DePuy denied wrongdoing as well as said they will appeal.
“We have no greater responsibility than to the patients who use our products, as well as our goal is actually to create medical innovations in which help people live more active as well as comfortable lives,” said Mindy Tinsley, spokeswoman for DePuy. “DePuy acted appropriately as well as responsibly inside the design as well as testing of ULTAMET Metal-on-Metal, as well as the product is actually backed by a strong track record of clinical data showing reduced pain as well as restored mobility for patients suffering by chronic hip pain.”
This specific is actually the third bellwether — or test — trial of thousands of similar lawsuits filed against the companies.
In March, a Dallas jury awarded more than $500 million to a group of plaintiffs who suffered similar complications by the hip implants. The judge in in which case, who also presided over This specific week’s ruling, later reduced the amount of awarded damages to $154 million, citing Texas law. Johnson & Johnson as well as DePuy have appealed in which ruling.
inside the first trial, in 2014, a jury ruled in favor of the medical companies.
A fourth bellwether trial is actually scheduled for September 2017.